Citron Research's Andrew left reiterated his bet against the Canadian cannabis industry, telling CNBC that he's short Canopy Growth and Cronos Group in addition to his already disclosed wager against Tilray.
from Finance https://ift.tt/2zU6eJJ
via IFTTT
from Finance https://ift.tt/2zU6eJJ
via IFTTT
Kommentare
Kommentar veröffentlichen